2015
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide
Publication
Publication
Journal of Clinical Endocrinology and Metabolism , Volume 100 - Issue 4 p. 1689- 1698
Copyright
Additional Metadata | |
---|---|
doi.org/10.1210/jc.2014-4350, hdl.handle.net/1765/82650 | |
Journal of Clinical Endocrinology and Metabolism | |
Organisation | Department of Internal Medicine |
Bengtsson, D, Schrøder, H.D, Andersen, M, Maiter, D, Berinder, K, Rasmussen, U.F, … Burman, P. (2015). Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide. Journal of Clinical Endocrinology and Metabolism, 100(4), 1689–1698. doi:10.1210/jc.2014-4350
|